6939.TWO TFBS Bioscience Inc.

Healthcare Diagnostics & Research Taiwan OTC Exchange
18.15 TWD
Close of Nov 5, 2026
17.10 27.85
Market cap
TWD 642M
P/E
-
P/B
0.57x
ROE
-6.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6939.TWO undervalued?

Graham number

The Graham number of TFBS Bioscience Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TFBS Bioscience Inc. fundamental analysis

No fundamental analysis for TFBS Bioscience Inc. yet.

TFBS Bioscience Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About TFBS Bioscience Inc.

TFBS Bioscience Inc., a contract research organization, provides biological testing services in Taiwan. It offers viral vector manufacturing services for cell and gene therapy products; and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products. The company was incorporated in 2016 and is headquartered in New Taipei City, Taiwan.

Full company profile